Copyright: ©Author(s) 2026.
World J Cardiol. Nov 26, 2026; 18(11): 124181
Published online Nov 26, 2026. doi: 10.4330/wjc.124181
Published online Nov 26, 2026. doi: 10.4330/wjc.124181
Figure 3 Network pharmacology of Xin-II in the treatment of chronic heart failure.
A: Identification of overlapping targets between Xin-II and heart failure; B: Regulatory network diagram of Xin-II-heart failure-interacting targets; C: Screening of key targets using five topological parameters; D: Enrichment analysis of biological processes and pathways; E: Identification of core targets for Xin-II in the treatment of chronic heart failure; F: Molecular docking results. HFrEF: Heart failure with reduced ejection fraction.
- Citation: Liu XJ, Cong Y, Zheng R, Li M, Xiu Z, Hu PF, Wu GH, Lianhua CG, Wan Q. Xin-II shows cardioprotective effects in a rat model of chronic heart failure: An integrated network pharmacology and transcriptomic. World J Cardiol 2026; 18(11): 124181
- URL: https://www.wjgnet.com/1949-8462/full/v18/i11/124181.htm
- DOI: https://dx.doi.org/10.4330/wjc.124181